Navigation Links
Thomson Scientific Publishes 'Who Is Making The Biggest Splash?' - a Quarterly Review of Scientific Literature on Drugs and Therapies From July - September 2007
Date:11/15/2007

Novartis Maintains its Top Spot, and Big Pharma Dominates Top Eight Slots

PHILADELPHIA and LONDON, Nov. 15 /PRNewswire-FirstCall/ -- Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and business communities, today announced the availability of the July-September issue of "Who is Making the Biggest Splash?"

In this quarterly review of the scientific literature on drugs and therapies, Thomson Scientific has assessed the quantity and quality of the materials published by pharmaceutical companies, research institutions and other non-commercial bodies in the last three months to identify which organization has made the biggest splash. The report provides an objective assessment of how this volume of research is being received within the clinical community and to give expert measured insight into organizations that helped to shape professional opinions.

Third Quarter Findings

Novartis maintained its top position for the second quarter in a row. Researchers affiliated with the firm issued 96 abstracts or scientific posters between July and September 2007, an increase on the 82 articles identified in the previous quarter. The company continues to perform well, with a solid Thomson Source Score of 75.

"Our data shows that clinicians are avid consumers of medical literature that can provide them with information about the benefits and problems associated with specific disease treatments. And it's clear that the Big Pharma companies dominating our leader-board are getting their message across," said Larry Liberti, VP, General Manager, Thomson Pharmaceutical Services. "Through using innovative mapping services such as Thomson Message Mapping System(SM), pharmaceutical companies build stronger communication programs and make the most of their publications budget."

Other key findings include:

-- Although Eli Lilly and AstraZeneca have swapped their second and third

positions, this quarter's top five companies were all in the top five

for the previous quarter.

-- Big Pharma features prominently, representing all entries except for

the US National Institutes of Health and Amylin Pharmaceuticals, a

growing biotechnology company.

-- Only one company, Janssen-Cilag (85%), exceeded a Thomson Source Score

of 80%.

-- The top eight entries are among the world's leading pharmaceutical

companies.

-- The US National Institutes of Mental Health and Abbott Laboratories

both dropped off the leader board this quarter, to be replaced by

Amylin Pharmaceuticals and Daiichi Sankyo

As a general assessment parameter, Thomson Source Scores of 80% or greater represent well-written articles based on solid science. While several companies approach this value (GlaxoSmithKline and Bristol-Myers Squibb with average values of 78%), Janssen-Cilag was the only organization among the top- 15 that exceeded the 80% mark this quarter.

Findings are based on information compiled by the Thomson Message Mapping System(SM) which provides data to the pharmaceutical industry in real-time, evaluating specific drugs and therapies against competitors as new studies are being published. By applying proprietary algorithms to assess both the quantity and quality of scientific literature on drugs and therapies from the point of view of the practicing clinician, the Thomson Message Mapping System(SM) helps pharmaceutical companies measure the overall impact of published scientific information.

For a full copy of the report with analysis, please visit: http://www.thomsonpharma.com/media/pdfs/tpqr/making-a-splash-sept2007.pdf

About The Thomson Corporation

The Thomson Corporation (http://www.thomson.com) is a global leader in providing essential electronic workflow solutions to business and professional customers. With operational headquarters in Stamford, Conn., Thomson provides value-added information, software tools and applications to professionals in the fields of law, tax, accounting, financial services, scientific research and healthcare. The Corporation's common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).

Thomson Scientific is a business of The Thomson Corporation. Its information solutions assist professionals at every stage of research and development-from discovery to analysis to product development and distribution. Thomson Scientific information solutions can be found at scientific.thomson.com.


'/>"/>
SOURCE Thomson Scientific
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Thomson Scientific Predicts Nobel Laureates
2. Thomson Scientific Announces BONDplus for Biological Researchers
3. Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows
4. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
5. Thomson Healthcare Endorsed as Preferred Vendor of Information Products and Services for Virginia Hospitals
6. Thomson Acquires Prous Science
7. Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
8. Thomson Scientific Ranks Australian Universities and Research Institutes
9. Thomson Scientific Launches Confessions ... of a User Campaign Asking Are You the New Face of Research?
10. Contract Renewal Extends Thomson Healthcares Long-Standing Relationship with University Hospitals
11. Thomson Healthcare Launches Application That Assesses Physician Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... July 24, 2017 , ... “Journey to the Light: The Quest for Happiness ... young woman’s path to finding herself. “Journey to the Light: The Quest for ... Grayson, an experienced writer of newsletters, manuals, and articles, who has recently decided to ...
(Date:7/23/2017)... ... July 23, 2017 , ... ... of education and training standards for healthcare treatment providers, offers healthcare professionals ... the iaedp™ Core Curriculum. , Presented as either online or as a ...
(Date:7/23/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 23, ... ... the effects of single sport specialization is critical, say researchers presenting their work ... Meeting in Toronto, Canada. , “Our study is the first one to ...
(Date:7/23/2017)... ... 23, 2017 , ... “I Am Not Nothin’: The Serpent Handler’s Daughter” is ... read and write and a brokenhearted young soldier who turned to whiskey after his ... about the power of simple faith is the work of published author Tommy G. ...
(Date:7/23/2017)... ... July 23, 2017 , ... Viora Ltd., a leading ... Patent No. 9,038,640 by the United States Patent and Trademark Office. The patent ... of Switching, Vacuum, and Cooling mechanisms to further increase the efficacy and safety ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... and EDMONTON, Alberta ... ) scientists and the University of Alberta in ... new data in Nature,s partner journal, Schizophrenia 1 ... helped predict instances of schizophrenia with 74% accuracy. ... the severity of specific symptoms in schizophrenia patients ...
(Date:7/20/2017)... PAUL, Minn. , July 20, 2017  Prime Therapeutics ... Jonathan Gavras , M.D., following today,s Institute for Clinical ... report on the effectiveness and value of abuse-deterrent ... manager on the policy roundtable at the meeting. ... is not a material cost benefit to the use of ...
(Date:7/14/2017)... International plc (NASDAQ: ENDP ) will announce its second-quarter ... senior management team will host a conference call and webcast before ... The dial-in number to access the call is U.S./ ... is 45397076. Please dial in 10 minutes prior to the scheduled ... of the call will be available from August 8, 2017 at ...
Breaking Medicine Technology: